Advanced Search (OLGA)

Gene: PIMREG (PICALM interacting mitotic regulator) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

PIMREG

Name:

PICALM interacting mitotic regulator

RGD ID:

1604005

HGNC Page

HGNC:25483

Description:

Predicted to be involved in cell division. Located in nucleolus and nucleoplasm.

Type:

protein-coding

RefSeq Status:

VALIDATED

Previously known as:

CALM interacting protein expressed in thymus and spleen; CALM-interactor expressed in thymus and spleen; CATS; FAM64A; family with sequence similarity 64 member A; family with sequence similarity 64, member A; FLJ10156; FLJ10491; RCS1; regulator of chromosome segregation 1; regulator of chromosome segregation protein 1

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Related Pseudogenes:

PIMREGP1 PIMREGP2 PIMREGP3 PIMREGP4

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	17	6,444,455 - 6,451,469 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	17	6,444,441 - 6,451,469 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	17	6,347,775 - 6,354,789 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	17	6,288,519 - 6,295,108 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	17	6,368,303 - 6,374,898 (+)	NCBI		Celera
Cytogenetic Map	17	p13.2	NCBI
HuRef	17	6,243,091 - 6,249,743 (+)	NCBI		HuRef
CHM1_1	17	6,357,166 - 6,363,816 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	17	6,344,181 - 6,351,199 (+)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
PIMREG	Human	cone-rod dystrophy 5		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Cone-rod dystrophy 5	ClinVar
PIMREG	Human	cone-rod dystrophy 5		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Cone-rod dystrophy 5	ClinVar	PMID:25741868
PIMREG	Human	congenital myasthenic syndrome 2A		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Congenital myasthenic syndrome 2A	ClinVar	PMID:28492532
PIMREG	Human	developmental and epileptic encephalopathy 25		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Developmental and epileptic encephalopathy and 25	ClinVar	PMID:10615133 more ...
PIMREG	Human	developmental and epileptic encephalopathy 25		IAGP	(Homo sapiens) and (Homo sapiens)	8554872	ClinVar Annotator: match by term: Developmental and epileptic encephalopathy and 25	ClinVar	PMID:28492532
PIMREG	Human	Leber congenital amaurosis 4		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Leber congenital amaurosis 4	ClinVar	PMID:10615133 more ...
PIMREG	Human	Leber congenital amaurosis 4		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Leber congenital amaurosis 4	ClinVar	PMID:28492532
PIMREG	Human	very long chain acyl-CoA dehydrogenase deficiency		IAGP	(Homo sapiens)	8554872	ClinVar Annotator: match by term: Very long chain acyl-CoA dehydrogenase deficiency	ClinVar	PMID:28492532

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
PIMREG	Human	1,2-dichloroethane	decreases expression	ISO	Pimreg (Mus musculus)	6480464	ethylene dichloride results in decreased expression of FAM64A mRNA	CTD	PMID:28960355
PIMREG	Human	1,2-dimethylhydrazine	increases expression	ISO	Pimreg (Mus musculus)	6480464	1 and 2-Dimethylhydrazine results in increased expression of FAM64A mRNA	CTD	PMID:22206623
PIMREG	Human	17beta-estradiol	increases expression	EXP		6480464	Estradiol results in increased expression of PIMREG mRNA	CTD	PMID:19167446
PIMREG	Human	17beta-estradiol	increases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Estradiol results in increased expression of FAM64A mRNA	CTD	PMID:32145629
PIMREG	Human	17beta-estradiol	increases expression	ISO	Pimreg (Mus musculus)	6480464	Estradiol results in increased expression of PIMREG mRNA	CTD	PMID:19484750
PIMREG	Human	2,2',4,4',5,5'-hexachlorobiphenyl	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[2 more ...	CTD	PMID:25510870
PIMREG	Human	2,2',5,5'-tetrachlorobiphenyl	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[2 more ...	CTD	PMID:25510870
PIMREG	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		6480464	Tetrachlorodibenzodioxin results in decreased expression of PIMREG mRNA	CTD	PMID:21802500
PIMREG	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Tetrachlorodibenzodioxin results in decreased expression of PIMREG mRNA	CTD	PMID:32109520
PIMREG	Human	2,3,7,8-tetrachlorodibenzodioxine	increases expression	ISO	Pimreg (Mus musculus)	6480464	Tetrachlorodibenzodioxin results in increased expression of PIMREG mRNA	CTD	PMID:26290441
PIMREG	Human	3,7-dihydropurine-6-thione	decreases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Mercaptopurine results in decreased expression of PIMREG mRNA	CTD	PMID:23358152
PIMREG	Human	4,4'-sulfonyldiphenol	decreases expression	ISO	Pimreg (Mus musculus)	6480464	bisphenol S results in decreased expression of PIMREG mRNA	CTD	PMID:39298647
PIMREG	Human	6-propyl-2-thiouracil	increases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Propylthiouracil results in increased expression of PIMREG mRNA	CTD	PMID:24780913
PIMREG	Human	acrolein	multiple interactions	EXP		6480464	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PIMREG mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PIMREG mRNA	CTD	PMID:32699268
PIMREG	Human	acrylamide	decreases expression	EXP		6480464	Acrylamide results in decreased expression of PIMREG mRNA	CTD	PMID:32763439
PIMREG	Human	aflatoxin M1	decreases expression	EXP		6480464	Aflatoxin M1 results in decreased expression of PIMREG mRNA	CTD	PMID:30928695
PIMREG	Human	aldehydo-D-glucose	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PIMREG mRNA	CTD	PMID:37567420
PIMREG	Human	all-trans-retinoic acid	decreases expression	EXP		6480464	Tretinoin results in decreased expression of PIMREG mRNA	CTD	PMID:23724009
PIMREG	Human	alpha-pinene	multiple interactions	EXP		6480464	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PIMREG mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of PIMREG mRNA	CTD	PMID:32699268
PIMREG	Human	arsenite(3-)	multiple interactions	EXP		6480464	arsenite promotes the reaction [G3BP1 protein binds to PIMREG mRNA]	CTD	PMID:32406909
PIMREG	Human	azathioprine	decreases expression	EXP		6480464	Azathioprine results in decreased expression of PIMREG mRNA	CTD	PMID:22623647
PIMREG	Human	benzo[a]pyrene	decreases expression	EXP		6480464	Benzo(a)pyrene results in decreased expression of PIMREG mRNA	CTD	PMID:20064835 and PMID:21802500
PIMREG	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of FAM64A 5' UTR	CTD	PMID:27901495
PIMREG	Human	benzo[a]pyrene	increases expression	ISO	Pimreg (Mus musculus)	6480464	Benzo(a)pyrene results in increased expression of PIMREG mRNA	CTD	PMID:32417428
PIMREG	Human	benzo[a]pyrene	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PIMREG mRNA	CTD	PMID:27858113
PIMREG	Human	benzo[a]pyrene diol epoxide I	decreases expression	EXP		6480464	7 more ...	CTD	PMID:20382639 and PMID:26238291
PIMREG	Human	benzo[b]fluoranthene	increases expression	ISO	Pimreg (Mus musculus)	6480464	benzo(b)fluoranthene results in increased expression of PIMREG mRNA	CTD	PMID:26377693
PIMREG	Human	benzo[b]fluoranthene	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PIMREG mRNA	CTD	PMID:27858113
PIMREG	Human	beta-lapachone	decreases expression	EXP		6480464	beta-lapachone results in decreased expression of PIMREG mRNA	CTD	PMID:38218311
PIMREG	Human	beta-lapachone	increases expression	EXP		6480464	beta-lapachone results in increased expression of PIMREG mRNA	CTD	PMID:38218311
PIMREG	Human	bis(2-chloroethyl) sulfide	decreases expression	EXP		6480464	Mustard Gas results in decreased expression of PIMREG mRNA	CTD	PMID:25102026
PIMREG	Human	bisphenol A	decreases expression	ISO	Pimreg (Rattus norvegicus)	6480464	bisphenol A results in decreased expression of PIMREG mRNA	CTD	PMID:25181051
PIMREG	Human	bisphenol A	affects expression	ISO	Pimreg (Rattus norvegicus)	6480464	bisphenol A affects the expression of FAM64A mRNA	CTD	PMID:32145629
PIMREG	Human	bisphenol A	decreases expression	EXP		6480464	bisphenol A results in decreased expression of PIMREG mRNA	CTD	PMID:29275510
PIMREG	Human	bisphenol A	increases expression	ISO	Pimreg (Rattus norvegicus)	6480464	bisphenol A results in increased expression of PIMREG mRNA	CTD	PMID:30816183 and PMID:32528016
PIMREG	Human	C60 fullerene	increases expression	ISO	Pimreg (Rattus norvegicus)	6480464	fullerene C60 results in increased expression of PIMREG mRNA	CTD	PMID:19167457
PIMREG	Human	caffeine	decreases phosphorylation	EXP		6480464	Caffeine results in decreased phosphorylation of PIMREG protein	CTD	PMID:35688186
PIMREG	Human	calcitriol	decreases expression	EXP		6480464	Calcitriol results in decreased expression of PIMREG mRNA	CTD	PMID:21592394
PIMREG	Human	calcitriol	multiple interactions	EXP		6480464	[Testosterone co-treated with Calcitriol] results in decreased expression of PIMREG mRNA	CTD	PMID:21592394
PIMREG	Human	carbon nanotube	increases expression	ISO	Pimreg (Mus musculus)	6480464	Nanotubes more ...	CTD	PMID:25554681
PIMREG	Human	chromium(6+)	multiple interactions	EXP		6480464	[zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of PIMREG mRNA	CTD	PMID:38479592
PIMREG	Human	chrysene	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PIMREG mRNA	CTD	PMID:27858113
PIMREG	Human	cobalt dichloride	decreases expression	EXP		6480464	cobaltous chloride results in decreased expression of PIMREG mRNA	CTD	PMID:19376846
PIMREG	Human	copper atom	multiple interactions	EXP		6480464	[NSC 689534 binds to Copper] which results in decreased expression of PIMREG mRNA	CTD	PMID:20971185
PIMREG	Human	copper(0)	multiple interactions	EXP		6480464	[NSC 689534 binds to Copper] which results in decreased expression of PIMREG mRNA	CTD	PMID:20971185
PIMREG	Human	copper(II) sulfate	decreases expression	EXP		6480464	Copper Sulfate results in decreased expression of PIMREG mRNA	CTD	PMID:19549813
PIMREG	Human	coumarin	affects phosphorylation	EXP		6480464	coumarin affects the phosphorylation of PIMREG protein	CTD	PMID:35688186
PIMREG	Human	coumestrol	increases expression	EXP		6480464	Coumestrol results in increased expression of PIMREG mRNA	CTD	PMID:19167446
PIMREG	Human	coumestrol	multiple interactions	EXP		6480464	[Coumestrol co-treated with 2 more ...	CTD	PMID:19167446
PIMREG	Human	crocidolite asbestos	increases expression	EXP		6480464	Asbestos and Crocidolite results in increased expression of PIMREG mRNA	CTD	PMID:29523930
PIMREG	Human	Cuprizon	increases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Cuprizone results in increased expression of PIMREG mRNA	CTD	PMID:26577399
PIMREG	Human	cyclosporin A	decreases expression	EXP		6480464	Cyclosporine results in decreased expression of PIMREG mRNA	CTD	PMID:21632981 and PMID:25562108
PIMREG	Human	D-glucose	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PIMREG mRNA	CTD	PMID:37567420
PIMREG	Human	DDE	increases expression	EXP		6480464	Dichlorodiphenyl Dichloroethylene results in increased expression of PIMREG mRNA	CTD	PMID:38568856
PIMREG	Human	diallyl trisulfide	decreases expression	EXP		6480464	diallyl trisulfide results in decreased expression of PIMREG mRNA	CTD	PMID:34995734
PIMREG	Human	dibenz[a,h]anthracene	increases expression	ISO	Pimreg (Mus musculus)	6480464	1 more ...	CTD	PMID:26377693
PIMREG	Human	dibutyl phthalate	decreases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Dibutyl Phthalate results in decreased expression of PIMREG mRNA	CTD	PMID:21266533
PIMREG	Human	dibutyl phthalate	decreases expression	ISO	Pimreg (Mus musculus)	6480464	Dibutyl Phthalate results in decreased expression of PIMREG mRNA	CTD	PMID:21266533
PIMREG	Human	dichloroacetic acid	increases expression	ISO	Pimreg (Mus musculus)	6480464	Dichloroacetic Acid results in increased expression of PIMREG mRNA	CTD	PMID:28962523
PIMREG	Human	dioxygen	decreases expression	EXP		6480464	Oxygen deficiency results in decreased expression of PIMREG mRNA	CTD	PMID:26516004
PIMREG	Human	dioxygen	multiple interactions	ISO	Pimreg (Rattus norvegicus)	6480464	[dan-shen root extract co-treated with Andrographis paniculata extract] inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PIMREG mRNA] and [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of PIMREG mRNA	CTD	PMID:33729688
PIMREG	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIMREG mRNA	CTD	PMID:27188386
PIMREG	Human	doxorubicin	increases expression	ISO	Pimreg (Mus musculus)	6480464	Doxorubicin results in increased expression of PIMREG mRNA	CTD	PMID:36227756
PIMREG	Human	Enterolactone	multiple interactions	EXP		6480464	[Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of PIMREG mRNA	CTD	PMID:19167446
PIMREG	Human	FR900359	decreases phosphorylation	EXP		6480464	FR900359 results in decreased phosphorylation of PIMREG protein	CTD	PMID:37730182
PIMREG	Human	fructose	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PIMREG mRNA	CTD	PMID:37567420
PIMREG	Human	glucose	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PIMREG mRNA	CTD	PMID:37567420
PIMREG	Human	glycidol	decreases expression	ISO	Pimreg (Rattus norvegicus)	6480464	glycidol results in decreased expression of PIMREG mRNA	CTD	PMID:24395379
PIMREG	Human	glyphosate	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose co-treated with Glyphosate] results in increased expression of PIMREG mRNA	CTD	PMID:37567420
PIMREG	Human	lead(0)	affects expression	EXP		6480464	Lead affects the expression of PIMREG mRNA	CTD	PMID:28903495
PIMREG	Human	leflunomide	decreases expression	EXP		6480464	leflunomide results in decreased expression of PIMREG mRNA	CTD	PMID:28988120
PIMREG	Human	lidocaine	increases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Lidocaine results in increased expression of FAM64A mRNA	CTD	PMID:35283115
PIMREG	Human	lipopolysaccharide	multiple interactions	EXP		6480464	[S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PIMREG mRNA	CTD	PMID:35811015
PIMREG	Human	menadione	affects expression	EXP		6480464	Vitamin K 3 affects the expression of PIMREG mRNA	CTD	PMID:20044591
PIMREG	Human	mercaptopurine	decreases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Mercaptopurine results in decreased expression of PIMREG mRNA	CTD	PMID:23358152
PIMREG	Human	methamphetamine	decreases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Methamphetamine results in decreased expression of PIMREG mRNA	CTD	PMID:28341135
PIMREG	Human	miconazole	increases expression	ISO	Pimreg (Mus musculus)	6480464	Miconazole results in increased expression of PIMREG mRNA	CTD	PMID:27462272
PIMREG	Human	N-methyl-4-phenylpyridinium	decreases expression	EXP		6480464	1-Methyl-4-phenylpyridinium results in decreased expression of PIMREG mRNA	CTD	PMID:24810058
PIMREG	Human	oxaliplatin	multiple interactions	ISO	Pimreg (Rattus norvegicus)	6480464	[oxaliplatin co-treated with Topotecan] results in decreased expression of PIMREG mRNA	CTD	PMID:25729387
PIMREG	Human	ozone	decreases expression	ISO	Pimreg (Mus musculus)	6480464	Ozone results in decreased expression of PIMREG mRNA	CTD	PMID:24336422
PIMREG	Human	ozone	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of PIMREG mRNA more ...	CTD	PMID:27106289 and PMID:34911549
PIMREG	Human	ozone	multiple interactions	EXP		6480464	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of PIMREG mRNA more ...	CTD	PMID:32699268
PIMREG	Human	palbociclib	decreases expression	EXP		6480464	palbociclib results in decreased expression of PIMREG mRNA	CTD	PMID:22869556
PIMREG	Human	paracetamol	decreases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Acetaminophen results in decreased expression of PIMREG mRNA	CTD	PMID:33387578
PIMREG	Human	PCB138	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[2 more ...	CTD	PMID:25510870
PIMREG	Human	phenylmercury acetate	decreases expression	EXP		6480464	Phenylmercuric Acetate results in decreased expression of PIMREG mRNA	CTD	PMID:26272509
PIMREG	Human	phenylmercury acetate	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIMREG mRNA	CTD	PMID:27188386
PIMREG	Human	propanal	decreases expression	EXP		6480464	propionaldehyde results in decreased expression of PIMREG mRNA	CTD	PMID:26079696
PIMREG	Human	purine-6-thiol	decreases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Mercaptopurine results in decreased expression of PIMREG mRNA	CTD	PMID:23358152
PIMREG	Human	quercetin	affects expression	ISO	Pimreg (Rattus norvegicus)	6480464	Quercetin affects the expression of PIMREG mRNA	CTD	PMID:18178720
PIMREG	Human	resveratrol	multiple interactions	EXP		6480464	[Coumestrol co-treated with Resveratrol] results in increased expression of PIMREG mRNA and [Plant Extracts co-treated with Resveratrol] results in decreased expression of PIMREG mRNA	CTD	PMID:19167446 and PMID:23557933
PIMREG	Human	S-(1,2-dichlorovinyl)-L-cysteine	multiple interactions	EXP		6480464	[S-(1 and 2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides] results in decreased expression of PIMREG mRNA	CTD	PMID:35811015
PIMREG	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PIMREG mRNA	CTD	PMID:27188386
PIMREG	Human	silicon dioxide	increases expression	ISO	Pimreg (Mus musculus)	6480464	Silicon Dioxide results in increased expression of FAM64A mRNA	CTD	PMID:29341224
PIMREG	Human	Soman	increases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Soman results in increased expression of PIMREG mRNA	CTD	PMID:19281266
PIMREG	Human	sunitinib	decreases expression	EXP		6480464	Sunitinib results in decreased expression of PIMREG mRNA	CTD	PMID:31533062
PIMREG	Human	testosterone	multiple interactions	EXP		6480464	[Testosterone co-treated with Calcitriol] results in decreased expression of PIMREG mRNA	CTD	PMID:21592394
PIMREG	Human	testosterone	decreases expression	EXP		6480464	Testosterone results in decreased expression of PIMREG mRNA	CTD	PMID:21592394
PIMREG	Human	tetraphene	multiple interactions	ISO	Pimreg (Mus musculus)	6480464	[Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PIMREG mRNA	CTD	PMID:27858113
PIMREG	Human	thapsigargin	decreases expression	EXP		6480464	Thapsigargin results in decreased expression of PIMREG mRNA	CTD	PMID:22378314
PIMREG	Human	titanium dioxide	increases methylation	ISO	Pimreg (Mus musculus)	6480464	titanium dioxide results in increased methylation of FAM64A promoter alternative form	CTD	PMID:35295148
PIMREG	Human	topotecan	multiple interactions	ISO	Pimreg (Rattus norvegicus)	6480464	[oxaliplatin co-treated with Topotecan] results in decreased expression of PIMREG mRNA	CTD	PMID:25729387
PIMREG	Human	trichloroethene	decreases expression	ISO	Pimreg (Rattus norvegicus)	6480464	Trichloroethylene results in decreased expression of PIMREG mRNA	CTD	PMID:33387578
PIMREG	Human	triclosan	decreases expression	EXP		6480464	Triclosan results in decreased expression of PIMREG mRNA	CTD	PMID:30510588
PIMREG	Human	trimellitic anhydride	increases expression	ISO	Pimreg (Mus musculus)	6480464	trimellitic anhydride results in increased expression of PIMREG mRNA	CTD	PMID:19042947
PIMREG	Human	trovafloxacin	decreases expression	ISO	Pimreg (Mus musculus)	6480464	trovafloxacin results in decreased expression of FAM64A mRNA	CTD	PMID:35537566
PIMREG	Human	tungsten	increases expression	ISO	Pimreg (Mus musculus)	6480464	Tungsten results in increased expression of FAM64A mRNA	CTD	PMID:30912803
PIMREG	Human	tunicamycin	decreases expression	EXP		6480464	Tunicamycin results in decreased expression of PIMREG mRNA	CTD	PMID:22378314 and PMID:29453283
PIMREG	Human	valproic acid	increases methylation	EXP		6480464	Valproic Acid results in increased methylation of PIMREG gene	CTD	PMID:29154799
PIMREG	Human	vinclozolin	increases methylation	ISO	Pimreg (Rattus norvegicus)	6480464	vinclozolin results in increased methylation of PIMREG gene	CTD	PMID:31682807
PIMREG	Human	zinc atom	decreases expression	EXP		6480464	Zinc results in decreased expression of PIMREG mRNA	CTD	PMID:19071009
PIMREG	Human	zinc(0)	decreases expression	EXP		6480464	Zinc results in decreased expression of PIMREG mRNA	CTD	PMID:19071009

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
PIMREG	Human	cell division	involved_in	IEA	UniProtKB-KW:KW-0132	150520179		UniProt	GO_REF:0000043

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
PIMREG	Human	nucleolus	located_in	IEA	UniProtKB-SubCell:SL-0188	150520179		UniProt	GO_REF:0000044
PIMREG	Human	nucleolus	located_in	IDA		150520179	PMID:16491119	HPA	GO_REF:0000052 and PMID:16491119
PIMREG	Human	nucleoplasm	located_in	IDA		150520179		HPA	GO_REF:0000052
PIMREG	Human	nucleus	located_in	IEA	UniProtKB-KW:KW-0539	150520179		UniProt	GO_REF:0000043
PIMREG	Human	nucleus	located_in	IEA	UniProtKB-SubCell:SL-0191	150520179		UniProt	GO_REF:0000044

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
PIMREG	Human	protein binding	enables	IPI	UniProtKB:P04156	150520179	PMID:18482256	IntAct	PMID:18482256
PIMREG	Human	protein binding	enables	IPI	UniProtKB:Q13492	150520179	PMID:16491119	BHF-UCL	PMID:16491119
PIMREG	Human	protein binding	enables	IPI	UniProtKB:P50402 more ...	150520179	PMID:32296183	IntAct	PMID:32296183
PIMREG	Human	protein binding	enables	IPI	UniProtKB:O95273 more ...	150520179	PMID:25416956	IntAct	PMID:25416956
PIMREG	Human	protein binding	enables	IPI	UniProtKB:O95273 more ...	150520179	PMID:26871637	IntAct	PMID:26871637

#	Reference Title	Reference Citation
1.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:8125298	PMID:12477932	PMID:14702039	PMID:15489334	PMID:16260042	PMID:18482256	PMID:18757745	PMID:19383357	PMID:21244100	PMID:21832049	PMID:23419774	PMID:25416956
PMID:26186194	PMID:26871637	PMID:27588395	PMID:28514442	PMID:30695070	PMID:30979502	PMID:30979686	PMID:31264076	PMID:32296183	PMID:32932948	PMID:33177704	PMID:33961781
PMID:34215720	PMID:35878427	PMID:35944360	PMID:36244648	PMID:37081231	PMID:37227120	PMID:37314216	PMID:37499664

PIMREG
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	17	6,444,455 - 6,451,469 (+)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	17	6,444,441 - 6,451,469 (+)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	17	6,347,775 - 6,354,789 (+)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	17	6,288,519 - 6,295,108 (+)	NCBI	NCBI36	Build 36	hg18	NCBI36
Celera	17	6,368,303 - 6,374,898 (+)	NCBI		Celera
Cytogenetic Map	17	p13.2	NCBI
HuRef	17	6,243,091 - 6,249,743 (+)	NCBI		HuRef
CHM1_1	17	6,357,166 - 6,363,816 (+)	NCBI		CHM1_1
T2T-CHM13v2.0	17	6,344,181 - 6,351,199 (+)	NCBI		T2T-CHM13v2.0

Pimreg
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	11	71,932,867 - 71,938,197 (+)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	11	71,932,858 - 71,938,196 (+)	Ensembl		GRCm39 Ensembl
GRCm38	11	72,042,428 - 72,047,372 (+)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	11	72,042,032 - 72,047,370 (+)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	11	71,856,004 - 71,860,872 (+)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	11	71,858,697 - 71,863,565 (+)	NCBI		MGSCv36	mm8
Celera	11	79,567,398 - 79,572,265 (+)	NCBI		Celera
Cytogenetic Map	11	B4	NCBI
cM Map	11	43.81	NCBI

Pimreg
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	10	57,168,136 - 57,173,713 (+)	NCBI		GRCr8
mRatBN7.2	10	56,669,603 - 56,674,540 (+)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	10	56,669,675 - 56,674,791 (+)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	10	61,333,647 - 61,338,494 (+)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	10	60,822,134 - 60,826,981 (+)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	10	56,321,186 - 56,326,033 (+)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	10	58,613,588 - 58,618,524 (+)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	10	58,613,674 - 58,618,514 (+)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	10	58,354,609 - 58,360,750 (+)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
RGSC_v3.4	10	58,895,262 - 58,900,104 (+)	NCBI	RGSC3.4	RGSC_v3.4	rn4	RGSC3.4
RGSC_v3.1	10	58,908,869 - 58,913,730 (+)	NCBI
Celera	10	55,800,601 - 55,805,442 (+)	NCBI		Celera
Cytogenetic Map	10	q24	NCBI

Pimreg
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955467	11,967,977 - 11,972,049 (+)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955467	11,967,986 - 11,972,049 (+)	NCBI	ChiLan1.0	ChiLan1.0

PIMREG
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	19	14,045,457 - 14,052,099 (+)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	17	16,011,515 - 16,018,156 (+)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	17	6,482,837 - 6,489,480 (+)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	17	6,471,520 - 6,478,156 (+)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	17	6,471,520 - 6,478,156 (+)	Ensembl	panpan1.1		panPan2

PIMREG
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	5	30,820,867 - 30,825,169 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
CanFam3.1 Ensembl	5	30,820,867 - 30,825,300 (-)	Ensembl	CanFam3.1		canFam3	CanFam3.1
Dog10K_Boxer_Tasha	5	30,952,548 - 30,956,850 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	5	30,922,550 - 30,926,870 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	5	30,922,550 - 30,927,714 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	5	30,887,362 - 30,891,663 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	5	30,846,408 - 30,850,707 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	5	31,019,761 - 31,024,063 (-)	NCBI		UU_Cfam_GSD_1.0

Pimreg
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024405602	54,366,142 - 54,371,329 (+)	NCBI		HiC_Itri_2
SpeTri2.0	NW_004936677	1,531,220 - 1,534,208 (-)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

PIMREG
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1 Ensembl	12	50,898,501 - 50,903,464 (-)	Ensembl	Sscrofa11.1		susScr11	Sscrofa11.1
Sscrofa11.1	12	50,898,493 - 50,903,238 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	12	52,896,983 - 52,901,847 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

PIMREG
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	16	5,824,323 - 5,829,908 (+)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
Vero_WHO_p1.0	NW_023666059	15,661,861 - 15,668,468 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Pimreg
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla 1.0	NW_004624786	7,568,097 - 7,573,485 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in PIMREG
35 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 17p13.2-13.1(chr17:5732977-8038822)x1	copy number loss	See cases [RCV000051043]	Chr17:5732977..8038822 [GRCh38] Chr17:5636297..7942140 [GRCh37] Chr17:5577021..7882865 [NCBI36] Chr17:17p13.2-13.1	pathogenic
GRCh38/hg38 17p13.2-13.1(chr17:3601515-7178024)x1	copy number loss	See cases [RCV000053406]	Chr17:3601515..7178024 [GRCh38] Chr17:3504809..7081343 [GRCh37] Chr17:3451558..7022067 [NCBI36] Chr17:17p13.2-13.1	pathogenic
GRCh38/hg38 17p13.2-13.1(chr17:6307904-8842949)x1	copy number loss	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053407]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053407]\|See cases [RCV000053407]	Chr17:6307904..8842949 [GRCh38] Chr17:6211224..8746266 [GRCh37] Chr17:6151948..8686991 [NCBI36] Chr17:17p13.2-13.1	pathogenic
GRCh38/hg38 17p13.3-13.1(chr17:162088-6959050)x1	copy number loss	See cases [RCV000134135]	Chr17:162088..6959050 [GRCh38] Chr17:45835..6862369 [GRCh37] Chr17:11879..6803093 [NCBI36] Chr17:17p13.3-13.1	pathogenic
GRCh38/hg38 17p13.3-13.1(chr17:198748-7491129)x3	copy number gain	See cases [RCV000134970]	Chr17:198748..7491129 [GRCh38] Chr17:50690..7394448 [GRCh37] Chr17:48539..7335172 [NCBI36] Chr17:17p13.3-13.1	pathogenic
GRCh38/hg38 17p13.2-12(chr17:5732953-12095349)x3	copy number gain	See cases [RCV000134851]	Chr17:5732953..12095349 [GRCh38] Chr17:5636273..11998666 [GRCh37] Chr17:5576997..11939391 [NCBI36] Chr17:17p13.2-12	pathogenic
GRCh38/hg38 17p13.3-13.1(chr17:162016-7697012)x1	copy number loss	See cases [RCV000138214]	Chr17:162016..7697012 [GRCh38] Chr17:45835..7600330 [GRCh37] Chr17:11807..7541055 [NCBI36] Chr17:17p13.3-13.1	pathogenic
GRCh38/hg38 17p13.2-13.1(chr17:6361393-7750863)x3	copy number gain	See cases [RCV000138220]	Chr17:6361393..7750863 [GRCh38] Chr17:6264713..7654181 [GRCh37] Chr17:6205437..7594906 [NCBI36] Chr17:17p13.2-13.1	likely pathogenic
GRCh38/hg38 17p13.3-12(chr17:162016-12343901)x3	copy number gain	See cases [RCV000138531]	Chr17:162016..12343901 [GRCh38] Chr17:45835..12247218 [GRCh37] Chr17:11807..12187943 [NCBI36] Chr17:17p13.3-12	pathogenic
GRCh38/hg38 17p13.3-12(chr17:150732-14764202)x3	copy number gain	See cases [RCV000142236]	Chr17:150732..14764202 [GRCh38] Chr17:525..14667519 [GRCh37] Chr17:525..14608244 [NCBI36] Chr17:17p13.3-12	pathogenic
GRCh37/hg19 17p13.2-13.1(chr17:6240267-6748728)x3	copy number gain	See cases [RCV000449261]	Chr17:6240267..6748728 [GRCh37] Chr17:17p13.2-13.1	uncertain significance
GRCh37/hg19 17p13.3-13.1(chr17:1113102-6742486)	copy number gain	See cases [RCV000445679]	Chr17:1113102..6742486 [GRCh37] Chr17:17p13.3-13.1	pathogenic
GRCh37/hg19 17p13.2(chr17:5871307-6472074)x4	copy number gain	See cases [RCV000510263]	Chr17:5871307..6472074 [GRCh37] Chr17:17p13.2	uncertain significance
GRCh37/hg19 17p13.3-q25.3(chr17:526-81041938)	copy number gain	See cases [RCV000511439]	Chr17:526..81041938 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-12(chr17:525-15027737)x3	copy number gain	See cases [RCV000511786]	Chr17:525..15027737 [GRCh37] Chr17:17p13.3-12	pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:526-81041938)x3	copy number gain	See cases [RCV000512441]	Chr17:526..81041938 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-12(chr17:525-11186432)x3	copy number gain	not provided [RCV000683866]	Chr17:525..11186432 [GRCh37] Chr17:17p13.3-12	pathogenic
NC_000017.10:g.(?_6328760)_(6616672_?)del	deletion	Developmental and epileptic encephalopathy, 25 [RCV000708070]\|Leber congenital amaurosis 4 [RCV001386952]	Chr17:6328760..6616672 [GRCh37] Chr17:17p13.2-13.1	pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:8547-81060040)x3	copy number gain	not provided [RCV000739324]	Chr17:8547..81060040 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:7214-81058310)x3	copy number gain	not provided [RCV000739320]	Chr17:7214..81058310 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.3-q25.3(chr17:12344-81057996)x3	copy number gain	not provided [RCV000739325]	Chr17:12344..81057996 [GRCh37] Chr17:17p13.3-q25.3	pathogenic
GRCh37/hg19 17p13.2-13.1(chr17:5892651-6850368)x3	copy number gain	not provided [RCV000751911]	Chr17:5892651..6850368 [GRCh37] Chr17:17p13.2-13.1	uncertain significance
NM_031220.4(PITPNM3):c.*3878G>A	single nucleotide variant	Cone-rod dystrophy 5 [RCV000338826]\|not provided [RCV004709723]	Chr17:6451460 [GRCh38] Chr17:6354780 [GRCh37] Chr17:17p13.2	benign
GRCh37/hg19 17p13.2-13.1(chr17:6246288-6558011)x3	copy number gain	not provided [RCV000847641]	Chr17:6246288..6558011 [GRCh37] Chr17:17p13.2-13.1	uncertain significance
NM_031220.4(PITPNM3):c.*4047C>T	single nucleotide variant	Cone-rod dystrophy 5 [RCV000293177]	Chr17:6451291 [GRCh38] Chr17:6354611 [GRCh37] Chr17:17p13.2	uncertain significance
NC_000017.10:g.(?_6328780)_(7128416_?)dup	duplication	Developmental and epileptic encephalopathy, 25 [RCV001320321]	Chr17:6328780..7128416 [GRCh37] Chr17:17p13.2-13.1	uncertain significance
NC_000017.10:g.(?_6328780)_(7606804_?)dup	duplication	Congenital myasthenic syndrome 2A [RCV003109217]\|Very long chain acyl-CoA dehydrogenase deficiency [RCV003119078]	Chr17:6328780..7606804 [GRCh37] Chr17:17p13.2-13.1	uncertain significance
NM_019013.3(PIMREG):c.82G>A (p.Glu28Lys)	single nucleotide variant	not specified [RCV004258861]	Chr17:6445192 [GRCh38] Chr17:6348512 [GRCh37] Chr17:17p13.2	uncertain significance
GRCh37/hg19 17p13.2-13.1(chr17:6248108-6637236)x1	copy number loss	not provided [RCV001836500]	Chr17:6248108..6637236 [GRCh37] Chr17:17p13.2-13.1	uncertain significance
NC_000017.10:g.(?_5289526)_(6616652_?)dup	duplication	Developmental and epileptic encephalopathy, 25 [RCV003113887]	Chr17:5289526..6616652 [GRCh37] Chr17:17p13.2-13.1	uncertain significance
NC_000017.10:g.(?_6328780)_(6428803_?)dup	duplication	Leber congenital amaurosis 4 [RCV003116741]\|not provided [RCV003116740]	Chr17:6328780..6428803 [GRCh37] Chr17:17p13.2	uncertain significance\|no classifications from unflagged records
NM_019013.3(PIMREG):c.677C>T (p.Ala226Val)	single nucleotide variant	not specified [RCV004253251]	Chr17:6449398 [GRCh38] Chr17:6352718 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.*64G>A	single nucleotide variant	not specified [RCV004255185]	Chr17:6450411 [GRCh38] Chr17:6353731 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.424C>G (p.Arg142Gly)	single nucleotide variant	not specified [RCV004321081]	Chr17:6447592 [GRCh38] Chr17:6350912 [GRCh37] Chr17:17p13.2	uncertain significance
GRCh38/hg38 17p13.3-12(chr17:165730-11404096)x3	copy number gain	Chromosome 17p13.3 duplication syndrome [RCV003327726]	Chr17:165730..11404096 [GRCh38] Chr17:17p13.3-12	pathogenic
NM_019013.3(PIMREG):c.551G>A (p.Arg184Gln)	single nucleotide variant	not specified [RCV004351695]	Chr17:6447719 [GRCh38] Chr17:6351039 [GRCh37] Chr17:17p13.2	uncertain significance
GRCh37/hg19 17p13.3-11.2(chr17:525-21510992)x3	copy number gain	not specified [RCV003987215]	Chr17:525..21510992 [GRCh37] Chr17:17p13.3-11.2	pathogenic
NM_019013.3(PIMREG):c.592G>A (p.Glu198Lys)	single nucleotide variant	not specified [RCV004505994]	Chr17:6449313 [GRCh38] Chr17:6352633 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.286G>A (p.Val96Met)	single nucleotide variant	not specified [RCV004505985]	Chr17:6445396 [GRCh38] Chr17:6348716 [GRCh37] Chr17:17p13.2	likely benign
NM_019013.3(PIMREG):c.361C>T (p.Arg121Trp)	single nucleotide variant	not specified [RCV004505988]	Chr17:6447529 [GRCh38] Chr17:6350849 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.362G>A (p.Arg121Gln)	single nucleotide variant	not specified [RCV004505989]	Chr17:6447530 [GRCh38] Chr17:6350850 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.613C>T (p.Pro205Ser)	single nucleotide variant	not specified [RCV004505995]	Chr17:6449334 [GRCh38] Chr17:6352654 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.650C>T (p.Ser217Phe)	single nucleotide variant	not specified [RCV004505996]	Chr17:6449371 [GRCh38] Chr17:6352691 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.8C>T (p.Ser3Phe)	single nucleotide variant	not specified [RCV004505997]	Chr17:6445118 [GRCh38] Chr17:6348438 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.187C>T (p.Leu63Phe)	single nucleotide variant	not specified [RCV004505984]	Chr17:6445297 [GRCh38] Chr17:6348617 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.346G>C (p.Val116Leu)	single nucleotide variant	not specified [RCV004505986]	Chr17:6447514 [GRCh38] Chr17:6350834 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.34G>A (p.Val12Met)	single nucleotide variant	not specified [RCV004505987]	Chr17:6445144 [GRCh38] Chr17:6348464 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.443C>A (p.Pro148His)	single nucleotide variant	not specified [RCV004505990]	Chr17:6447611 [GRCh38] Chr17:6350931 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.496C>T (p.Arg166Trp)	single nucleotide variant	not specified [RCV004505991]	Chr17:6447664 [GRCh38] Chr17:6350984 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.524G>A (p.Arg175Gln)	single nucleotide variant	not specified [RCV004505992]	Chr17:6447692 [GRCh38] Chr17:6351012 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.538G>C (p.Glu180Gln)	single nucleotide variant	not specified [RCV004505993]	Chr17:6447706 [GRCh38] Chr17:6351026 [GRCh37] Chr17:17p13.2	uncertain significance
NC_000017.10:g.(?_422368)_(8285628_?)dup	duplication	not provided [RCV004581443]	Chr17:422368..8285628 [GRCh37] Chr17:17p13.3-13.1	uncertain significance
NM_019013.3(PIMREG):c.35T>G (p.Val12Gly)	single nucleotide variant	not specified [RCV004657245]	Chr17:6445145 [GRCh38] Chr17:6348465 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.106C>G (p.Gln36Glu)	single nucleotide variant	not specified [RCV004648283]	Chr17:6445216 [GRCh38] Chr17:6348536 [GRCh37] Chr17:17p13.2	uncertain significance
GRCh37/hg19 17p13.2-12(chr17:4678235-14745263)x3	copy number gain	not provided [RCV004819316]	Chr17:4678235..14745263 [GRCh37] Chr17:17p13.2-12	pathogenic
NM_019013.3(PIMREG):c.425G>A (p.Arg142Gln)	single nucleotide variant	not specified [RCV004844601]	Chr17:6447593 [GRCh38] Chr17:6350913 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.347T>C (p.Val116Ala)	single nucleotide variant	not specified [RCV004844602]	Chr17:6447515 [GRCh38] Chr17:6350835 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.563C>G (p.Ser188Cys)	single nucleotide variant	not specified [RCV004844609]	Chr17:6447731 [GRCh38] Chr17:6351051 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.193G>A (p.Ala65Thr)	single nucleotide variant	not specified [RCV004844610]	Chr17:6445303 [GRCh38] Chr17:6348623 [GRCh37] Chr17:17p13.2	likely benign
NM_019013.3(PIMREG):c.*65C>T	single nucleotide variant	not specified [RCV004844611]	Chr17:6450412 [GRCh38] Chr17:6353732 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.142A>G (p.Arg48Gly)	single nucleotide variant	not specified [RCV004844612]	Chr17:6445252 [GRCh38] Chr17:6348572 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.484C>T (p.Arg162Cys)	single nucleotide variant	not specified [RCV004844600]	Chr17:6447652 [GRCh38] Chr17:6350972 [GRCh37] Chr17:17p13.2	likely benign
NM_019013.3(PIMREG):c.38G>T (p.Arg13Leu)	single nucleotide variant	not specified [RCV004844603]	Chr17:6445148 [GRCh38] Chr17:6348468 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.684G>C (p.Glu228Asp)	single nucleotide variant	not specified [RCV004844604]	Chr17:6449405 [GRCh38] Chr17:6352725 [GRCh37] Chr17:17p13.2	likely benign
NM_019013.3(PIMREG):c.462C>A (p.Asp154Glu)	single nucleotide variant	not specified [RCV004844605]	Chr17:6447630 [GRCh38] Chr17:6350950 [GRCh37] Chr17:17p13.2	likely benign
NM_019013.3(PIMREG):c.191G>A (p.Arg64His)	single nucleotide variant	not specified [RCV004844606]	Chr17:6445301 [GRCh38] Chr17:6348621 [GRCh37] Chr17:17p13.2	uncertain significance
NM_019013.3(PIMREG):c.94G>A (p.Val32Met)	single nucleotide variant	not specified [RCV004844607]	Chr17:6445204 [GRCh38] Chr17:6348524 [GRCh37] Chr17:17p13.2	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	2862
Count of miRNA genes:	922
Interacting mature miRNAs:	1120
Transcripts:	ENST00000250056, ENST00000570337, ENST00000571373, ENST00000571572, ENST00000572447, ENST00000572595, ENST00000573385, ENST00000573557, ENST00000576056
Prediction methods:	Miranda, Pita, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

RH15958

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	6,354,741 - 6,354,880	UniSTS	GRCh37
Build 36	17	6,295,465 - 6,295,604	RGD	NCBI36
Celera	17	6,375,255 - 6,375,394	RGD
Cytogenetic Map	17	p13.2	UniSTS
Cytogenetic Map	17	p13	UniSTS
HuRef	17	6,250,099 - 6,250,238	UniSTS
GeneMap99-GB4 RH Map	17	46.9	UniSTS
NCBI RH Map	17	101.7	UniSTS

RH104452

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	17	6,354,133 - 6,354,278	UniSTS	GRCh37
GRCh37	4	106,447,205 - 106,447,351	UniSTS	GRCh37
Build 36	4	106,666,654 - 106,666,800	RGD	NCBI36
Celera	4	103,746,329 - 103,746,475	RGD
Celera	17	6,374,647 - 6,374,792	UniSTS
Cytogenetic Map	17	p13	UniSTS
Cytogenetic Map	17	p13.2	UniSTS
HuRef	4	102,181,699 - 102,181,845	UniSTS
HuRef	17	6,249,491 - 6,249,636	UniSTS
GeneMap99-GB4 RH Map	17	51.68	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	renal system	reproductive system	respiratory system	sensory system	visual system
1181	2391	2500	2040	4766	1647	2269	5	553	1832	398	2257	6659	6113	52	3521	832	1716	1604	172	1


RefSeq Transcripts	NM_001195228	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_019013	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_017024778	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047436310	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047436311	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_047436312	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054316530	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054316531	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054316532	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	XM_054316533	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AC055872	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK001018	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK001353	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK225613	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK225702	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC005004	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC013966	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471108	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068261	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KU178653	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	KU178654	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000250056 ⟹ ENSP00000250056

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	6,444,441 - 6,451,065 (+)	Ensembl

Ensembl Acc Id:

ENST00000570337 ⟹ ENSP00000460894

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	6,444,443 - 6,450,365 (+)	Ensembl

Ensembl Acc Id:

ENST00000571373 ⟹ ENSP00000459597

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	6,444,443 - 6,449,938 (+)	Ensembl

Ensembl Acc Id:

ENST00000571572 ⟹ ENSP00000459860

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	6,447,495 - 6,450,595 (+)	Ensembl

Ensembl Acc Id:

ENST00000572447 ⟹ ENSP00000459235

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	6,444,455 - 6,451,469 (+)	Ensembl

Ensembl Acc Id:

ENST00000572595 ⟹ ENSP00000458584

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	6,444,446 - 6,451,055 (+)	Ensembl

Ensembl Acc Id:

ENST00000573385

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	6,447,347 - 6,449,549 (+)	Ensembl

Ensembl Acc Id:

ENST00000573557 ⟹ ENSP00000460912

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	6,444,442 - 6,450,441 (+)	Ensembl

Ensembl Acc Id:

ENST00000576056 ⟹ ENSP00000458534

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	17	6,444,475 - 6,450,291 (+)	Ensembl

RefSeq Acc Id:

NM_001195228 ⟹ NP_001182157

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	6,444,455 - 6,451,469 (+)	NCBI
GRCh37	17	6,347,735 - 6,354,385 (+)	ENTREZGENE
HuRef	17	6,243,091 - 6,249,743 (+)	ENTREZGENE
CHM1_1	17	6,357,166 - 6,363,816 (+)	NCBI
T2T-CHM13v2.0	17	6,344,181 - 6,351,199 (+)	NCBI

Sequence:

show sequence

GTGCTGCGGCTGTGCTCGGCCTTAGTGGTGTCGGGGTCTAGTGGACAGAGAAGACTCTTGGCCAGGCAGATGGCTTCTCGGTGGCAGAACATGGGGACCTCCGTGCGCCGGAGATCTCTCCAGCACCA
GGAGCAGCTGGAGGACAGCAAGGAGCTGCAGCCTGTGGTCAGCCATCAGGAGACCTCTGTAGGGGCCCTGGGGTCCCTGTGCAGACAGTTCCAAAGGAGGCTGCCCCTGAGAGCCGTCAACCTCAACC
TCCGCGCAGGGCCCTCCTGGAAACGCCTGGAAACCCCAGAGCCAGGTCAGCAGGGCCTCCAGGCTGCAGCTCGCTCAGCTAAGAGTGCTTTGGGTGCCGTGTCCCAGAGAATCCAGGAGTCCTGCCAA
AGTGGCACCAAGTGGCTGGTGGAGACCCAGGTGAAGGCCAGGAGGCGGAAGAGAGGAGCACAGAAGGGCAGTGGATCCCCAACTCACAGCCTGAGCCAGAAGAGCACCCGGCTGTCTGGAGCCGCCCC
TGCCCACTCAGCCGCAGACCCCTGGGAGAAGGAGCATCACCGCCTCTCTGTCCGGATGGGCTCACATGCCCACCCATTACGGCGATCAAGGCGGGAGGCTGCCTTCCGGAGCCCCTACTCCTCAACAG
AGCCCCTCTGCTCTCCCAGCGAGTCTGACAGTGACCTAGAGCCTGTGGGGGCGGGAATTCAGCATCTCCAGAAGCTGTCCCAAGAGCTAGATGAAGCCATTATGGCGGAAGAGAGGAAACAAGCCCTG
TCTGACCGCCAAGGCTTCATACTCAAGGATGTCTATGCTTCCCCGTGAGCTTCCTGGAAAAAACCCCCGGGAGTCGTCAGTACCCCTGGGCCACTGCTAACAAGCACCTAACAAGGGGCCCAGAGCCC
CCTGCTCCAGCCACATCTGGACCCATCAGTGACTGCCTGCCATAGCCTGAGAGTGTCTTGGGGAGACCTTGCAGAGGGGGAGAATTGTTCCTTCTGCTTTCCTAGGGGACTCTTGAGCTTAGAAACTC
ATCGTACACTTGACCTTGAGCCTTCTATTTGCCTCATCTATAACATGAAGTGCTAGCATCAGATATTTGAGAGCTCTTAGCTCTGTACCCGGGTGCCTGGTTTTTGGGGAGTCATCCGCAGAGTCACT
CACCCACTGTGTTTCTGGTGCCAAGGCTCTTGAGGGCCCCACTCTCATCCCTCCTTTCCCTACCAGGGACTCGGAGGAAGGCATAGGAGATATTTCCAGGCTTACGACCCTGGGCTCACGGGTACCTA
TTTATATGCTCAGTGCAGAGCACTGTGGATGTGCCAGGAGGGGTAGCCCTGTTCAAGAGCAATTTCTGCCCTTTGTAAATTATTTAAGAAACCTGCTTTGTCATTTTATTAGAAAGAAACCAGCGTGT
GACTTTCCTAGATAACACTGCTTTCTCATAATAAAGACTATTTGCATTTGACATCTGTTCCCTTTCACCGGCAACCTCCAACCTCCCCCGCCCTCCCACACCACTCTGGGCTATAGATTTGTAATTTG
TGGTTTGGGGTCTGGCCCTCATCCACCTCTGCTCCGAGCCAGTCTGCCCCCAATCCCACCCCAGGGAGAACATGTAGAAAGGGAAAGGTTTCTCAACTTAGTTCAGACCAAAACACATTGTAAAGGCA
AAGAAGGTTTTTATTTAAGTGACAACATTTGAGAGCTAAAAACCAGCTCACATCAAAATCAAGACCCAGTTGTAAAAATCTTTTAACTCCATAATGCTGTTTTTGTCTTGTTAGAAATCTGATATCTT
ACATTAGCGTTTCTAACGGATTTTGTACAAGGCAGCCATAAGGAATATAATAAACCTTTTTCACCACAGAA

hide sequence

RefSeq Acc Id:

NM_019013 ⟹ NP_061886

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	6,444,455 - 6,451,469 (+)	NCBI
GRCh37	17	6,347,735 - 6,354,385 (+)	ENTREZGENE
Build 36	17	6,288,519 - 6,295,108 (+)	NCBI Archive
Celera	17	6,368,303 - 6,374,898 (+)	RGD
HuRef	17	6,243,091 - 6,249,743 (+)	ENTREZGENE
CHM1_1	17	6,357,166 - 6,363,816 (+)	NCBI
T2T-CHM13v2.0	17	6,344,181 - 6,351,199 (+)	NCBI

Sequence:

show sequence

GTGCTGCGGCTGTGCTCGGCCTTAGTGGTGTCGGGGTCTAGTGGACAGAGAAGACTCTTGGCCAGGCAGATGGCTTCTCGGTGGCAGAACATGGGGACCTCCGTGCGCCGGAGATCTCTCCAGCACCA
GGAGCAGCTGGAGGACAGCAAGGAGCTGCAGCCTGTGGTCAGCCATCAGGAGACCTCTGTAGGGGCCCTGGGGTCCCTGTGCAGACAGTTCCAAAGGAGGCTGCCCCTGAGAGCCGTCAACCTCAACC
TCCGCGCAGGGCCCTCCTGGAAACGCCTGGAAACCCCAGAGCCAGGTCAGCAGGGCCTCCAGGCTGCAGCTCGCTCAGCTAAGAGTGCTTTGGGTGCCGTGTCCCAGAGAATCCAGGAGTCCTGCCAA
AGTGGCACCAAGTGGCTGGTGGAGACCCAGGTGAAGGCCAGGAGGCGGAAGAGAGGAGCACAGAAGGGCAGTGGATCCCCAACTCACAGCCTGAGCCAGAAGAGCACCCGGCTGTCTGGAGCCGCCCC
TGCCCACTCAGCCGCAGACCCCTGGGAGAAGGAGCATCACCGCCTCTCTGTCCGGATGGGCTCACATGCCCACCCATTACGGCGATCAAGGCGGGAGGCTGCCTTCCGGAGCCCCTACTCCTCAACAG
AGCCCCTCTGCTCTCCCAGCGAGTCTGACAGTGACCTAGAGCCTGTGGGGGCGGGAATTCAGCATCTCCAGAAGCTGTCCCAAGAGCTAGATGAAGCCATTATGGCGGAAGAGAGTGGTGACATCGTC
TCTCTCATTCATGACTGAGGAAGTGCCTGCAGGAAACAAGCCCTGTCTGACCGCCAAGGCTTCATACTCAAGGATGTCTATGCTTCCCCGTGAGCTTCCTGGAAAAAACCCCCGGGAGTCGTCAGTAC
CCCTGGGCCACTGCTAACAAGCACCTAACAAGGGGCCCAGAGCCCCCTGCTCCAGCCACATCTGGACCCATCAGTGACTGCCTGCCATAGCCTGAGAGTGTCTTGGGGAGACCTTGCAGAGGGGGAGA
ATTGTTCCTTCTGCTTTCCTAGGGGACTCTTGAGCTTAGAAACTCATCGTACACTTGACCTTGAGCCTTCTATTTGCCTCATCTATAACATGAAGTGCTAGCATCAGATATTTGAGAGCTCTTAGCTC
TGTACCCGGGTGCCTGGTTTTTGGGGAGTCATCCGCAGAGTCACTCACCCACTGTGTTTCTGGTGCCAAGGCTCTTGAGGGCCCCACTCTCATCCCTCCTTTCCCTACCAGGGACTCGGAGGAAGGCA
TAGGAGATATTTCCAGGCTTACGACCCTGGGCTCACGGGTACCTATTTATATGCTCAGTGCAGAGCACTGTGGATGTGCCAGGAGGGGTAGCCCTGTTCAAGAGCAATTTCTGCCCTTTGTAAATTAT
TTAAGAAACCTGCTTTGTCATTTTATTAGAAAGAAACCAGCGTGTGACTTTCCTAGATAACACTGCTTTCTCATAATAAAGACTATTTGCATTTGACATCTGTTCCCTTTCACCGGCAACCTCCAACC
TCCCCCGCCCTCCCACACCACTCTGGGCTATAGATTTGTAATTTGTGGTTTGGGGTCTGGCCCTCATCCACCTCTGCTCCGAGCCAGTCTGCCCCCAATCCCACCCCAGGGAGAACATGTAGAAAGGG
AAAGGTTTCTCAACTTAGTTCAGACCAAAACACATTGTAAAGGCAAAGAAGGTTTTTATTTAAGTGACAACATTTGAGAGCTAAAAACCAGCTCACATCAAAATCAAGACCCAGTTGTAAAAATCTTT
TAACTCCATAATGCTGTTTTTGTCTTGTTAGAAATCTGATATCTTACATTAGCGTTTCTAACGGATTTTGTACAAGGCAGCCATAAGGAATATAATAAACCTTTTTCACCACAGAA

hide sequence

RefSeq Acc Id:

XM_017024778 ⟹ XP_016880267

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	6,445,411 - 6,451,469 (+)	NCBI

Sequence:

show sequence

CTGACAACACTAATCATCTTTTTTATGGAGTGTTTCCTTGGTGCCAGGCAGTTCCTGCCCTCAAAGAGCCTCAAGAATATAGACTTCATGAAAACAGGGACGTTGGTTAGTTCACTGCTGTTTCCCCA
CCACCCCAGATAGTTCCTGGCACATATAGGTGCTCAACAAATAGTTGAATGAGTGAATGAAAGCATGTCTTGGAGGAAACAGATGCTCACAATACCAGGTGATAAGAGCTGTACGTGATAGGAAATTG
CAAAGCAAGTGACCAATAGTGAGGCTCACCAAATGCAAGCTTAGTCGGTGAAGGCTTCCCAGAGGAGGTGATTCCAGAGTTCACCCAGGGAAGCAAAGGTCAAGGGGTATTTAGGGTAGGGGAAATAG
TGCAAGTCCAGGCCTAGAGCTGAGGGAAAGCAAGGTGTACTGCCCACTCAGCTGTGTATCCCTGAGGAGAGCCAGAATTGTAGTCTGGGTATGAACAGATGACAGAGAGCAAGGTAGAGCAGGGGGAA
AGGATATGAAGGAGCTTAGAACTCTCCCAGGAATGATCAGGAGTCCGGAAGATTCTAAACAGTGGAAAGTCTGGTCTAATTAGCATATTAGAATTTGCCCTTTAGCTACATGATGGAGAAGGGAATAG
AGGCAGAGATGCTCCTGATGGAGACTAAGGGTTTGGACTTGCAGGGGATAAACTTCAGGAGCTGCCGAGAAGGTCCAGTTAGAGGGGATTTGCTGTCAAATGAGAGCTGCTGTCAGGAAGACGTCCTT
ATATTGGATAGAATCCAGGAGTCCTGCCAAAGTGGCACCAAGTGGCTGGTGGAGACCCAGGTGAAGGCCAGGAGGCGGAAGAGAGGAGCACAGAAGGGCAGTGGATCCCCAACTCACAGCCTGAGCCA
GAAGAGCACCCGGCTGTCTGGAGCCGCCCCTGCCCACTCAGCCGCAGACCCCTGGGAGAAGGAGCATCACCGCCTCTCTGTCCGGATGGGCTCACATGCCCACCCATTACGGCGATCAAGGCGGGAGG
CTGCCTTCCGGAGCCCCTACTCCTCAACAGAGCCCCTCTGCTCTCCCAGCGAGTCTGACAGTGACCTAGAGCCTGTGGGGGCGGGAATTCAGCATCTCCAGAAGCTGTCCCAAGAGCTAGATGAAGCC
ATTATGGCGGAAGAGAGGAAACAAGCCCTGTCTGACCGCCAAGGCTTCATACTCAAGGATGTCTATGCTTCCCCGTGAGCTTCCTGGAAAAAACCCCCGGGAGTCGTCAGTACCCCTGGGCCACTGCT
AACAAGCACCTAACAAGGGGCCCAGAGCCCCCTGCTCCAGCCACATCTGGACCCATCAGTGACTGCCTGCCATAGCCTGAGAGTGTCTTGGGGAGACCTTGCAGAGGGGGAGAATTGTTCCTTCTGCT
TTCCTAGGGGACTCTTGAGCTTAGAAACTCATCGTACACTTGACCTTGAGCCTTCTATTTGCCTCATCTATAACATGAAGTGCTAGCATCAGATATTTGAGAGCTCTTAGCTCTGTACCCGGGTGCCT
GGTTTTTGGGGAGTCATCCGCAGAGTCACTCACCCACTGTGTTTCTGGTGCCAAGGCTCTTGAGGGCCCCACTCTCATCCCTCCTTTCCCTACCAGGGACTCGGAGGAAGGCATAGGAGATATTTCCA
GGCTTACGACCCTGGGCTCACGGGTACCTATTTATATGCTCAGTGCAGAGCACTGTGGATGTGCCAGGAGGGGTAGCCCTGTTCAAGAGCAATTTCTGCCCTTTGTAAATTATTTAAGAAACCTGCTT
TGTCATTTTATTAGAAAGAAACCAGCGTGTGACTTTCCTAGATAACACTGCTTTCTCATAATAAAGACTATTTGCATTTGA

hide sequence

RefSeq Acc Id:

XM_047436310 ⟹ XP_047292266

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	6,444,455 - 6,451,065 (+)	NCBI

RefSeq Acc Id:

XM_047436311 ⟹ XP_047292267

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	6,444,455 - 6,451,065 (+)	NCBI

RefSeq Acc Id:

XM_047436312 ⟹ XP_047292268

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	6,445,411 - 6,451,065 (+)	NCBI

RefSeq Acc Id:

XM_054316530 ⟹ XP_054172505

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	17	6,344,181 - 6,350,795 (+)	NCBI

RefSeq Acc Id:

XM_054316531 ⟹ XP_054172506

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	17	6,344,181 - 6,350,795 (+)	NCBI

RefSeq Acc Id:

XM_054316532 ⟹ XP_054172507

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	17	6,345,137 - 6,351,199 (+)	NCBI

RefSeq Acc Id:

XM_054316533 ⟹ XP_054172508

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
T2T-CHM13v2.0	17	6,345,137 - 6,350,795 (+)	NCBI


Protein RefSeqs	NP_001182157	(Get FASTA)	NCBI Sequence Viewer
	NP_061886	(Get FASTA)	NCBI Sequence Viewer
	XP_016880267	(Get FASTA)	NCBI Sequence Viewer
	XP_047292266	(Get FASTA)	NCBI Sequence Viewer
	XP_047292267	(Get FASTA)	NCBI Sequence Viewer
	XP_047292268	(Get FASTA)	NCBI Sequence Viewer
	XP_054172505	(Get FASTA)	NCBI Sequence Viewer
	XP_054172506	(Get FASTA)	NCBI Sequence Viewer
	XP_054172507	(Get FASTA)	NCBI Sequence Viewer
	XP_054172508	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAH05004	(Get FASTA)	NCBI Sequence Viewer
	AAH13966	(Get FASTA)	NCBI Sequence Viewer
	ALQ34111	(Get FASTA)	NCBI Sequence Viewer
	ALQ34112	(Get FASTA)	NCBI Sequence Viewer
	BAA91468	(Get FASTA)	NCBI Sequence Viewer
	BAA91644	(Get FASTA)	NCBI Sequence Viewer
	EAW90306	(Get FASTA)	NCBI Sequence Viewer
	EAW90307	(Get FASTA)	NCBI Sequence Viewer
	EAW90308	(Get FASTA)	NCBI Sequence Viewer
	EAW90309	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000250056
	ENSP00000250056.8
	ENSP00000458534
	ENSP00000458534.1
	ENSP00000459235
	ENSP00000459235.1
	ENSP00000459597
GenBank Protein	Q9BSJ6	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_061886 ⟸ NM_019013
- Peptide Label:	isoform 1
- UniProtKB:	A0A0S2Z5C7 (UniProtKB/TrEMBL), I3L156 (UniProtKB/TrEMBL)
- Sequence:	show sequence MASRWQNMGTSVRRRSLQHQEQLEDSKELQPVVSHQETSVGALGSLCRQFQRRLPLRAVNLNLRAGPSWKRLETPEPGQQGLQAAARSAKSALGAVSQRIQESCQSGTKWLVETQVKARRRKRGAQKG SGSPTHSLSQKSTRLSGAAPAHSAADPWEKEHHRLSVRMGSHAHPLRRSRREAAFRSPYSSTEPLCSPSESDSDLEPVGAGIQHLQKLSQELDEAIMAEESGDIVSLIHD hide sequence

RefSeq Acc Id:	NP_001182157 ⟸ NM_001195228
- Peptide Label:	isoform 2
- UniProtKB:	Q9NVV1 (UniProtKB/Swiss-Prot), Q96CT4 (UniProtKB/Swiss-Prot), Q9NWB5 (UniProtKB/Swiss-Prot), Q9BSJ6 (UniProtKB/Swiss-Prot), A0A0S2Z5F0 (UniProtKB/TrEMBL), I3L156 (UniProtKB/TrEMBL)
- Sequence:	show sequence MASRWQNMGTSVRRRSLQHQEQLEDSKELQPVVSHQETSVGALGSLCRQFQRRLPLRAVNLNLRAGPSWKRLETPEPGQQGLQAAARSAKSALGAVSQRIQESCQSGTKWLVETQVKARRRKRGAQKG SGSPTHSLSQKSTRLSGAAPAHSAADPWEKEHHRLSVRMGSHAHPLRRSRREAAFRSPYSSTEPLCSPSESDSDLEPVGAGIQHLQKLSQELDEAIMAEERKQALSDRQGFILKDVYASP hide sequence

RefSeq Acc Id:

XP_016880267 ⟸ XM_017024778

- Peptide Label:

isoform X3

- Sequence:

show sequence

MMEKGIEAEMLLMETKGLDLQGINFRSCREGPVRGDLLSNESCCQEDVLILDRIQESCQSGTKWLVETQVKARRRKRGAQKGSGSPTHSLSQKSTRLSGAAPAHSAADPWEKEHHRLSVRMGSHAHPL
RRSRREAAFRSPYSSTEPLCSPSESDSDLEPVGAGIQHLQKLSQELDEAIMAEERKQALSDRQGFILKDVYASP

hide sequence

Ensembl Acc Id:

ENSP00000460894 ⟸ ENST00000570337

Ensembl Acc Id:

ENSP00000459860 ⟸ ENST00000571572

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q9BSJ6-F1-model_v2	AlphaFold	Q9BSJ6	1-248	view protein structure

RGD ID:

6794135

Promoter ID:

HG_KWN:24813

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, HeLa_S3, K562, Lymphoblastoid

Transcripts:

UC002GDA.1, UC002GDB.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	17	6,287,936 - 6,288,436 (+)	MPROMDB

RGD ID:

6794137

Promoter ID:

HG_KWN:24812

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell_12Hour, Jurkat, Lymphoblastoid

Transcripts:

ENST00000250056, ENST00000405197, NM_019013, UC002GCT.1, UC002GCV.1, UC002GCX.1, UC002GCY.1, UC002GCZ.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	17	6,287,961 - 6,288,512 (+)	MPROMDB

RGD ID:

7233579

Promoter ID:

EPDNEW_H22535

Type:

initiation region

Name:

FAM64A_1

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Experiment Methods:

Single-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	17	6,444,455 - 6,444,515	EPDNEW

Database	Acc Id	Source(s)
COSMIC	PIMREG	COSMIC
Ensembl Genes	ENSG00000129195	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000250056	ENTREZGENE
	ENST00000250056.12	UniProtKB/Swiss-Prot
	ENST00000571373	ENTREZGENE
	ENST00000572447	ENTREZGENE
	ENST00000572447.6	UniProtKB/Swiss-Prot
	ENST00000576056	ENTREZGENE
	ENST00000576056.5	UniProtKB/Swiss-Prot
GTEx	ENSG00000129195	GTEx
HGNC ID	HGNC:25483	ENTREZGENE
Human Proteome Map	PIMREG	Human Proteome Map
InterPro	RCS1	UniProtKB/Swiss-Prot
KEGG Report	hsa:54478	UniProtKB/Swiss-Prot
NCBI Gene	54478	ENTREZGENE
OMIM	617611	OMIM
PANTHER	PROTEIN PIMREG	UniProtKB/Swiss-Prot
	PTHR35819	UniProtKB/Swiss-Prot
Pfam	RCS1	UniProtKB/Swiss-Prot
PharmGKB	PA142671874	PharmGKB
UniProt	A0A0S2Z5C7	ENTREZGENE, UniProtKB/TrEMBL
	A0A0S2Z5F0	ENTREZGENE, UniProtKB/TrEMBL
	I3L156	ENTREZGENE, UniProtKB/TrEMBL
	I3L2R2_HUMAN	UniProtKB/TrEMBL
	I3L419	ENTREZGENE, UniProtKB/TrEMBL
	I3L427_HUMAN	UniProtKB/TrEMBL
	PIMRE_HUMAN	UniProtKB/Swiss-Prot
	Q96CT4	ENTREZGENE
	Q9BSJ6	ENTREZGENE
	Q9NVV1	ENTREZGENE
	Q9NWB5	ENTREZGENE
UniProt Secondary	Q96CT4	UniProtKB/Swiss-Prot
	Q9NVV1	UniProtKB/Swiss-Prot
	Q9NWB5	UniProtKB/Swiss-Prot

Nomenclature History

Date	Current Symbol	Current Name	Previous Symbol	Previous Name	Description	Reference	Status
2017-02-28	PIMREG	PICALM interacting mitotic regulator	FAM64A	family with sequence similarity 64 member A	Symbol and/or name change	5135510	APPROVED
2015-11-24	FAM64A	family with sequence similarity 64 member A		family with sequence similarity 64, member A	Symbol and/or name change	5135510	APPROVED

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message

Imported Disease Annotations - ClinVar